CD163 and metabolic dysfunction-associated steatotic liver disease: In our study, sCD163 was the only independent predictor of MAFLD with steatohepatitis, and recent studies showed that this marker of macrophage activation is associated with morphological disease grade and that a high concentration of sCD163 predicts advanced fibrosis (>F3 or above) in NAFLD [25,26].